Added to YB: 2023-07-18
Pitch date: 2023-07-18
HYPE3:BZ [bullish]
Hypera S.A.
-40.96%
current return
Author Info
No bio for this author
Company Info
Hypera S.A. operates as a pharmaceutical company in Brazil. It offers prescription products under the Adacne, Addera, apri, AmpliumG, pleased, Celestamine, Celestone, Celestone Soluspan, Cizax, deciprax, Derive C Micro, Micro Drift, Dermotil Fusid, Digedrat, diprogent, Diprosalic, Diprosone, diprospan, Emprol XR, Flow, Garasone, Halobex, Lipanon, Luna, moon, Lydian, macrodantin, MaxSulid, Milgamma, Mioflex – A, Nesina, Novotram, oximax, peridal, Peridal Suspension, PredSim, Pressaliv, Quadriderm, Rizi, Rizi M, Softalm, Tacroz, Tinodin, Umma, and velunid brands.
Market Cap
BRL 11.7B
Pitch Price
BRL 40.08
Price Target
N/A
Dividend
3.67%
EV/EBITDA
7.84
P/E
7.53
EV/Sales
2.45
Sector
Pharmaceuticals
Category
N/A
Hypera S.A. HYPE3:BZ
A summary for this pitch has not been created yet.
Read full article (0 min)